Sign in to view content

Interaction of Genotypes and AREDS Formulation Use in the Development of Neovascular AMD

Pradeepa Yoganathan, MSc, MD, FRCS(C)

Video
Published 2019

Related

Pooled Clinical Trial Safety Data of Neurotrophic Factorâ€“Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
Paul S. Bernstein, MD, PhD
Annual Meeting Talks
2024
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Development of a Novel Retinal Tamponade Agent to Replace Fluorinated Gas and Silicone Oil
James A Stefater, MD, PhD
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more